The present study provides experimental evidence that transgenics expressing human IL-37 aggravate DSS-induced colitis, which is strongly linked to intestinal barrier defects and pathogenic bacteria invasion, both of which might promote immune cell recruitment to exacerbate inflammatory responses. Here, IL37 is linked to colitis.